Table 1.
Characteristics of subjects with reliable LSMs by both methods.
| Parameter (Mean ± SD) | n = 204 |
|---|---|
| Age (years) | 54.7 ± 11.7 |
| Gender | |
| Males | 111/204 (54.4%) |
| Females | 93/204 (45.6%) |
| BMI (kg/m2) | 31.2± 5.5 |
| Abdominal Circumference (cm) | 108.7 ± 11.3 |
| AST (UI/L) | 39 ± 27.7 |
| ALT (UI/L) | 51.1 ± 41.1 |
| GGT (mg/dL) | 89.4 ± 97.1 |
| Cholesterol (mg/dL) | 201.4 ± 49.1 |
| LDLc (mg/dL) | 126.8 ± 45.9 |
| HDLc (mg/dL) | 43.9 ± 10.7 |
| Triglyceride (mg/dL) | 198.5 ± 155.1 |
| CAP (dB/m) | 328.5 ± 43.6 |
| LS by TE (kPa) | 7.7 ± 3.1 |
| 2D-SWE.PLUS (kPa) | 6.2 ± 2.7 |
| SSp.PLUS (m/s) | 1524.3 ± 28.8 |
| Att.PLUS (dB/cm/MHz) | 0.4 ± 0.1 |
| Vi.PLUS (Pa.S) | 1.8 ± 0.3 |
| Liver fibrosis distribution by TE | |
| F0–1 | 84.4% (172/204) |
| F2 | 3.9% (8/204) |
| F3 | 9.8% (20/204) |
| F4 | 1.9% (4/204) |
| Liver steatosis distribution by CAP | |
| S0 | 20.6% (42/204) |
| S1 | 9.3% (19/204) |
| S2 | 21.1% (43/204) |
| S3 | 49.0% (100/204) |
Data are presented as number and percentage or mean ± standard deviation; ALT = alanine aminotransferase, AST = aspartate aminotransferase, BMI = body mass index, LS = liver stiffness, TE = Transient Elastography, CAP = Controlled Attenuation Parameter, 2D-SWE.PLUS = Two-Dimensional Shear Wave PLUS Elastography by SuperSonic Imagine, SSp.PLUS = Sound Speed Plane-wave UltraSound, Att.PLUS = Attenuation Plane-wave UltraSound, Vi.PLUS = Viscosity Plane-wave UltraSound.